Analysis of the Gut-Brain Axis in Aging: Implications in Alzheimer Disease
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ABSTRACT
The gut microbiome consists of the shared
genome of the community of trillions of
commensal,
symbiotic,
and
pathogenic
microorganisms residing in the gastrointestinal
ecosystem. The interaction between the host and
its gut microbiome, as well as the Gut-Bran Axis
(GBA), is a complex relationship whose
management could prove critical to preventing or
treating not only various gut disorders, such as
irritable bowel syndrome (IBS) or behavioral health
disorders like general depression and anxiety, but
also central nervous system (CNS) disorders,
such as Alzheimer's (AD) and Parkinson's (PD)
diseases. The purpose of this review is to
summarize what is currently known about the gut
microbiome, how it is connected to the
development of disease pathology and to identify
the bacterial and biochemical targets/pathways
that should be the focus of future research. In
identifying, exploring, and understanding the
mechanisms behind the activity and propagation
of the gut microbiome, this will provide us new
insights that are likely to pave the way for
increased novel therapeutic strategies.

Areas of the brain affected by CNS-based disease pathologies and medications/therapies commonly used to treat symptoms in affected
persons.
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The bi-directional relationship of the gut/gut microbiota and the brain/central nervous
system (CNS).
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Several inflammatory factors such as cytokines and endotoxins, as well as neurotransmitters, and
antimicrobial peptides, play a significant role in the development or potential mitigation of various
pathologies and are present and active in the gut microbiota.
Modified from: https://www.semanticscholar.org/paper/Neuromicrobiology%3A-How-Microbes-Influence-the-Fuente-Nu%C3%B1ez-Meneguetti/c2deb682f76a962b30e29f562a8cd97e2d1c61bc
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